By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged...
Patient Advocacy and Support
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
Navigating the "New Normal": Breast Cancer Canada Launches Comprehensive Survivorship Webinar Series
Navigating the "New Normal": Breast Cancer Canada Launches Comprehensive Survivorship Webinar Series
By Journal Staff For many breast cancer patients, the sound of the "victory bell" marking the end...
By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, primarily...
NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
NEW YORK CITY — In a pivotal moment for the global oncology community, the Breast Cancer Research...
The journey through breast cancer is often depicted as a linear progression: diagnosis, treatment, and recovery. However,...
An In-depth Examination of Emerging Research and Clinical Considerations In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists...
NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global...
NEW YORK, NY — In a move that has sent ripples through the global scientific and philanthropic...
